Windtree Therapeutics (WINT) Revenue & Revenue Breakdown
Windtree Therapeutics Revenue Highlights
00
Windtree Therapeutics Revenue by Period
Windtree Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-12-31 | - | 100.00% |
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | -100.00% |
2019-12-31 | $198.00K | -88.93% |
2018-12-31 | $1.79M | 20.40% |
2017-12-31 | $1.49M | -27.28% |
2016-12-31 | $2.04M | 106.89% |
2015-12-31 | $987.00K | -65.19% |
2014-12-31 | $2.83M | 630.67% |
2013-12-31 | $388.00K | 98.97% |
2012-12-31 | $195.00K | -66.49% |
2011-12-31 | $582.00K | 100.00% |
2010-12-31 | - | 100.00% |
2009-12-31 | - | -100.00% |
2008-12-31 | $4.60M | 100.00% |
2007-12-31 | - | 100.00% |
2006-12-31 | - | -100.00% |
2005-12-31 | $134.00K | -88.92% |
2004-12-31 | $1.21M | 16.59% |
2003-12-31 | $1.04M | -41.81% |
2002-12-31 | $1.78M | 60.25% |
2001-12-31 | $1.11M | 50.07% |
2000-12-31 | $741.00K | 316.29% |
1999-12-31 | $178.00K | 78.00% |
1998-12-31 | $100.00K | -85.71% |
1997-12-31 | $700.00K | 250.00% |
1996-12-31 | $200.00K | 100.00% |
1995-12-31 | $100.00K | - |
Windtree Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Windtree Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2025-03-31 | - | -100.00% |
2024-12-31 | $45.00K | 100.00% |
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | 100.00% |
2023-12-31 | - | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | -100.00% |
2020-12-31 | $23.68M | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | -100.00% |
2019-06-30 | $158.00K | 295.00% |
2019-03-31 | $40.00K | -86.84% |
2018-12-31 | $304.00K | 32.75% |
2018-09-30 | $229.00K | -78.21% |
2018-06-30 | $1.05M | 415.20% |
2018-03-31 | $204.00K | 100.00% |
2017-12-31 | $102.00K | 500.00% |
2017-09-30 | $17.00K | -98.52% |
2017-06-30 | $1.15M | 423.74% |
2017-03-31 | $219.00K | -75.67% |
2016-12-31 | $900.00K | -6.35% |
2016-09-30 | $961.00K | 806.60% |
2016-06-30 | $106.00K | 41.33% |
2016-03-31 | $75.00K | -88.55% |
2015-12-31 | $655.00K | 892.42% |
2015-09-30 | $66.00K | -12.00% |
2015-06-30 | $75.00K | -60.73% |
2015-03-31 | $191.00K | -83.87% |
2014-12-31 | $1.18M | 124.67% |
2014-09-30 | $527.00K | -51.78% |
2014-06-30 | $1.09M | 3425.81% |
2014-03-31 | $31.00K | -57.53% |
2013-12-31 | $73.00K | 21.67% |
2013-09-30 | $60.00K | -67.03% |
2013-06-30 | $182.00K | 152.78% |
2013-03-31 | $72.00K | -63.08% |
2012-12-31 | $195.00K | 100.00% |
2012-09-30 | - | 100.00% |
2012-06-30 | - | 100.00% |
2012-03-31 | - | 100.00% |
2011-12-31 | - | 100.00% |
2011-09-30 | - | -100.00% |
2011-06-30 | $201.00K | -47.24% |
2011-03-31 | $381.00K | 100.00% |
2010-12-31 | - | 100.00% |
2010-09-30 | - | 100.00% |
2010-06-30 | - | 100.00% |
2010-03-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2009-09-30 | - | 100.00% |
2009-06-30 | - | 100.00% |
2009-03-31 | - | 100.00% |
2008-12-31 | - | -100.00% |
2008-09-30 | $50.00K | -98.00% |
2008-06-30 | $2.50M | 21.95% |
2008-03-31 | $2.05M | 100.00% |
2007-12-31 | - | - |
Windtree Therapeutics generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Windtree Therapeutics Revenue Breakdown
Windtree Therapeutics Revenue Breakdown by Product
Quarterly Revenue by Product
Product/Service | Jun 19 |
---|---|
License | $158.00K |
Latest
Windtree Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Jun 19: License (100.00%).
Windtree Therapeutics Revenue Breakdown by Country
Quarterly Revenue by Country
Country | Jun 19 |
---|---|
License | $158.00K |
Latest
Windtree Therapeutics's latest quarterly revenue breakdown by geography, as of Jun 19: License (100.00%).